
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $8.6M | $8.3M | $23.7M | $52.4M | $82.3M | |
Gross Profit | -$8.6M | -$8.3M | -$23.7M | -$52.4M | -$82.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $648K | $3.7M | $4.4M | $6.6M | $6.4M | |
Selling, General & Admin | $28M | $57.6M | $53.2M | $54.9M | $56.7M | |
Other Inc / (Exp) | -$11.7M | -$1.3M | -$6.1M | $33.3M | -$92.2M | |
Operating Expenses | $28.6M | $61.3M | $57.6M | $61.5M | $63.1M | |
Operating Income | -$37.2M | -$69.6M | -$81.3M | -$113.9M | -$145.4M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$53M | -$77.5M | -$84.7M | -$101.1M | -$289.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $650K | -$79K | |
Net Income to Company | -$53M | -$77.5M | -$84.7M | -$101.7M | -$289.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$53M | -$77.5M | -$84.7M | -$101.7M | -$289.1M | |
Basic EPS (Cont. Ops) | -$1.96 | -$0.75 | -$0.54 | -$0.62 | -$1.75 | |
Diluted EPS (Cont. Ops) | -$1.96 | -$0.79 | -$0.55 | -$0.63 | -$1.75 | |
Weighted Average Basic Share | $28.7M | $102.9M | $156M | $163.9M | $165.4M | |
Weighted Average Diluted Share | $28.7M | $103M | $156.2M | $164M | $165.4M | |
EBITDA | -$47M | -$67.7M | -$77.2M | -$50.8M | -$197.7M | |
EBIT | -$48.9M | -$70M | -$82.4M | -$69.7M | -$232.4M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$37.2M | -$69.6M | -$81.3M | -$113.9M | -$145.4M | |
Operating Income (Adjusted) | -$48.9M | -$70M | -$82.4M | -$69.7M | -$232.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | $1.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $2.1M | $4M | $7.4M | $21.2M | $23.3M | |
Gross Profit | -$2.1M | -$4M | -$7.4M | -$21.2M | -$21.7M | |
Gross Profit Margin | -- | -- | -- | -- | -1373.54% | |
R&D Expenses | $547K | $339K | $1.8M | $1.8M | $1.5M | |
Selling, General & Admin | $7.6M | $14.7M | $12.7M | $16M | $14.5M | |
Other Inc / (Exp) | -$13.7M | -$5.9M | -$5.3M | -$35.2M | $61.2M | |
Operating Expenses | $8.2M | $15.1M | $14.4M | $17.8M | $16M | |
Operating Income | -$10.3M | -$19.1M | -$21.8M | -$39M | -$37.7M | |
Net Interest Expenses | -- | -- | -- | -- | $14.7M | |
EBT. Incl. Unusual Items | -$26.1M | -$25.4M | -$25.8M | -$85.6M | $8.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$26.1M | -$25.4M | -$25.8M | -$85.6M | $8.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$26.1M | -$25.4M | -$25.8M | -$85.6M | $8.8M | |
Basic EPS (Cont. Ops) | -$0.51 | -$0.19 | -$0.16 | -$0.52 | $0.05 | |
Diluted EPS (Cont. Ops) | -$0.51 | -$0.19 | -$0.16 | -$0.52 | $0.05 | |
Weighted Average Basic Share | $51.2M | $133.2M | $163.6M | $164.4M | $177.3M | |
Weighted Average Diluted Share | $51.2M | $133.2M | $163.8M | $164.4M | $178.5M | |
EBITDA | -$23.5M | -$18M | -$23M | -$60.5M | $32.4M | |
EBIT | -$24M | -$19.1M | -$25.2M | -$70.6M | $23.9M | |
Revenue (Reported) | -- | -- | -- | -- | $1.6M | |
Operating Income (Reported) | -$10.3M | -$19.1M | -$21.8M | -$39M | -$37.7M | |
Operating Income (Adjusted) | -$24M | -$19.1M | -$25.2M | -$70.6M | $23.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $9.1M | $10.2M | $27M | $66.2M | $84.4M | |
Gross Profit | -$9.1M | -$10.2M | -$27M | -$66.2M | -$82.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $847K | $3.5M | $5.8M | $6.7M | $6.1M | |
Selling, General & Admin | $34.4M | $64.7M | $51.2M | $58.2M | $55.2M | |
Other Inc / (Exp) | -$24.7M | $6.6M | -$5.5M | $3.5M | $4.2M | |
Operating Expenses | $35.2M | $68.2M | $57M | $64.8M | $61.3M | |
Operating Income | -$44.3M | -$78.4M | -$84M | -$131.1M | -$144.1M | |
Net Interest Expenses | -- | -- | -- | -- | $14.7M | |
EBT. Incl. Unusual Items | -$74.5M | -$76.9M | -$85.2M | -$160.8M | -$194.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$74.5M | -$76.9M | -$85.2M | -$161.5M | -$194.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$74.5M | -$76.9M | -$85.2M | -$161.5M | -$194.7M | |
Basic EPS (Cont. Ops) | -$2.19 | -$0.60 | -$0.51 | -$0.99 | -$1.17 | |
Diluted EPS (Cont. Ops) | -$2.19 | -$0.64 | -$0.52 | -$1.01 | -$1.17 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$67M | -$76M | -$81.6M | -$88.4M | -$104.8M | |
EBIT | -$68.9M | -$78.9M | -$87.9M | -$115.1M | -$137.9M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$44.3M | -$78.4M | -$84M | -$131.1M | -$144.1M | |
Operating Income (Adjusted) | -$68.9M | -$78.9M | -$87.9M | -$115.1M | -$137.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | $1.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $2.1M | $4M | $7.4M | $21.2M | $23.3M | |
Gross Profit | -$2.1M | -$4M | -$7.4M | -$21.2M | -$21.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $547K | $339K | $1.8M | $1.8M | $1.5M | |
Selling, General & Admin | $7.6M | $14.7M | $12.7M | $16M | $14.5M | |
Other Inc / (Exp) | -$13.7M | -$5.9M | -$5.3M | -$35.2M | $61.2M | |
Operating Expenses | $8.2M | $15.1M | $14.4M | $17.8M | $16M | |
Operating Income | -$10.3M | -$19.1M | -$21.8M | -$39M | -$37.7M | |
Net Interest Expenses | -- | -- | -- | -- | $14.7M | |
EBT. Incl. Unusual Items | -$26.1M | -$25.4M | -$25.8M | -$85.6M | $8.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$26.1M | -$25.4M | -$25.8M | -$85.6M | $8.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$26.1M | -$25.4M | -$25.8M | -$85.6M | $8.8M | |
Basic EPS (Cont. Ops) | -$0.51 | -$0.19 | -$0.16 | -$0.52 | $0.05 | |
Diluted EPS (Cont. Ops) | -$0.51 | -$0.19 | -$0.16 | -$0.52 | $0.05 | |
Weighted Average Basic Share | $51.2M | $133.2M | $163.6M | $164.4M | $177.3M | |
Weighted Average Diluted Share | $51.2M | $133.2M | $163.8M | $164.4M | $178.5M | |
EBITDA | -$23.5M | -$18M | -$23M | -$60.5M | $32.4M | |
EBIT | -$24M | -$19.1M | -$25.2M | -$70.6M | $23.9M | |
Revenue (Reported) | -- | -- | -- | -- | $1.6M | |
Operating Income (Reported) | -$10.3M | -$19.1M | -$21.8M | -$39M | -$37.7M | |
Operating Income (Adjusted) | -$24M | -$19.1M | -$25.2M | -$70.6M | $23.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $64.5M | $33.4M | $63.9M | $73.4M | $15.7M | |
Short Term Investments | -- | $167.4M | $98.6M | $48.2M | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | $4.8M | $8.1M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $446K | $2.7M | $4.9M | $10.5M | $13.5M | |
Total Current Assets | $64.9M | $345.3M | $236.2M | $162.6M | $53.9M | |
Property Plant And Equipment | $74.1M | $225.2M | $524.9M | $668.5M | $730.9M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $269M | $94.1M | $100.3M | $208.2M | $13.6M | |
Total Assets | $408M | $664.7M | $861.3M | $1B | $798.4M | |
Accounts Payable | $1.1M | $1.4M | $1.7M | $2.9M | $6.6M | |
Accrued Expenses | $31.9M | $37.1M | $36.6M | $43.6M | $50.9M | |
Current Portion Of Long-Term Debt | $122K | -- | -- | $9.1M | $23.3M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | $10.1M | |
Total Current Liabilities | $33.1M | $38.5M | $38.3M | $55.6M | $90.9M | |
Long-Term Debt | $262.2M | $232.5M | $233.5M | $507.4M | $323.4M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $296.2M | $283.1M | $350.5M | $619.1M | $617.9M | |
Common Stock | $82K | $128K | $164K | $164K | $174K | |
Other Common Equity Adj | -- | -$237K | -$641K | -$32K | $78K | |
Common Equity | $192.4M | $539.3M | $510.9M | $420.2M | $180.4M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $111.7M | $381.5M | $510.9M | $420.2M | $180.4M | |
Total Liabilities and Equity | $408M | $664.7M | $861.3M | $1B | $798.4M | |
Cash and Short Terms | $64.5M | $200.8M | $162.5M | $121.6M | $15.7M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $252.5M | $198.2M | $38.4M | $25M | $22.5M | |
Short Term Investments | -- | $219.8M | -- | $2.2M | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | $1.5M | |
Inventory | -- | -- | -- | -- | $8.7M | |
Prepaid Expenses | $4.6M | -- | -- | -- | -- | |
Other Current Assets | $2.2M | $3.2M | $7.4M | $16.4M | $11.2M | |
Total Current Assets | $259.3M | $521.3M | $113.8M | $51.2M | $49.7M | |
Property Plant And Equipment | $108.4M | $280.3M | $598.5M | $670.8M | $724M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $317.5M | $97.2M | $163.1M | $12M | $13.6M | |
Total Assets | $685.3M | $898.8M | $875.4M | $734M | $787.3M | |
Accounts Payable | $1.5M | $1.8M | $22.6M | $8.4M | $6.8M | |
Accrued Expenses | $28.9M | $25.5M | $48M | $32M | $32.9M | |
Current Portion Of Long-Term Debt | $265K | -- | -- | -- | $23.1M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | $27.9M | |
Total Current Liabilities | $30.6M | $27.3M | $70.6M | $43.6M | $90.6M | |
Long-Term Debt | $289M | $232.8M | $233.8M | $284.4M | $340.3M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $343.9M | $335.6M | $387.9M | $397.2M | $549.1M | |
Common Stock | $117K | $163K | $164K | $165K | $180K | |
Other Common Equity Adj | -- | -$577K | -- | $2K | -$16K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $341.3M | $563.2M | $487.6M | $336.8M | $238.2M | |
Total Liabilities and Equity | $685.3M | $898.8M | $875.4M | $734M | $787.3M | |
Cash and Short Terms | $252.5M | $417.9M | $38.4M | $27.2M | $22.5M | |
Total Debt | -- | -- | -- | -- | $363.4M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$53M | -$77.5M | -$84.7M | -$101.7M | -$289.1M | |
Depreciation & Amoritzation | $1.9M | $2.3M | $5.2M | $18.9M | $34.7M | |
Stock-Based Compensation | $5.6M | $22.6M | $10.8M | $11.8M | $11.7M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -$265K | -$4.5M | -$3.3M | |
Cash From Operations | -$18M | -$54.5M | -$65.5M | -$94.9M | -$144.8M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$29.8M | -$305.6M | -$218.4M | -$102.1M | -$7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $304.1M | -- | -- | $285.1M | $66.1M | |
Long-Term Debt Repaid | -$18.7M | -- | -- | -$592K | -$259.7M | |
Repurchase of Common Stock | -- | -$1.7M | -$1.6M | -$1.4M | -$1.6M | |
Other Financing Activities | -$14.3M | -$4.4M | -$831K | -$11.1M | -$4.1M | |
Cash From Financing | $378.2M | $293.4M | $247.5M | $272M | -$109.2M | |
Beginning Cash (CF) | $150K | $330.6M | $263.9M | $227.5M | $302.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $330.4M | -$66.7M | -$36.3M | $75M | -$261M | |
Ending Cash (CF) | $330.6M | $263.9M | $227.5M | $302.5M | $41.5M | |
Levered Free Cash Flow | -$47.8M | -$191.9M | -$352.7M | -$248.8M | -$200.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$26.1M | -$25.4M | -$25.8M | -$85.6M | $8.8M | |
Depreciation & Amoritzation | $490K | $1.1M | $2.2M | $10M | $8.5M | |
Stock-Based Compensation | $307K | $3.2M | $2.2M | $2.7M | $3.4M | |
Change in Accounts Receivable | -- | -- | -- | -- | -$1.5M | |
Change in Inventories | -- | -- | -- | -$648K | -$596K | |
Cash From Operations | -$20.6M | -$16.9M | -$14.8M | -$39.2M | -$38.9M | |
Capital Expenditures | -- | -- | -- | -- | $15M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$33.9M | -$105.1M | $52.7M | $32M | -$15M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | $16.4M | |
Long-Term Debt Repaid | -- | -- | -- | -$253.2M | -- | |
Repurchase of Common Stock | -- | -$1M | -$277K | -$598K | -$1.7M | |
Other Financing Activities | -$4.5M | -$785K | -$1.4M | -$1.7M | -$3.4M | |
Cash From Financing | $294M | $248.2M | -$1.6M | -$255.4M | $49.8M | |
Beginning Cash (CF) | $330.6M | $263.9M | $227.5M | $302.5M | $41.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $239.5M | $126.2M | $36.4M | -$262.6M | -$4M | |
Ending Cash (CF) | $570.1M | $390M | $263.9M | $39.9M | $37.5M | |
Levered Free Cash Flow | -$54.5M | -$69.1M | -$61.4M | -$53.5M | -$53.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$74.5M | -$76.9M | -$85.2M | -$161.5M | -$194.7M | |
Depreciation & Amoritzation | $1.9M | $2.9M | $6.3M | $26.7M | $33.2M | |
Stock-Based Compensation | $5.5M | $25.5M | $9.8M | $12.3M | $12.3M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -$5.1M | -$3.2M | |
Cash From Operations | -$33.6M | -$50.9M | -$63.3M | -$119.3M | -$144.5M | |
Capital Expenditures | -- | -- | -- | -- | $15M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$62.9M | -$376.7M | -$60.6M | -$122.8M | -$54M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $285.1M | $82.5M | |
Long-Term Debt Repaid | -- | -- | -- | -$253.8M | -$6.5M | |
Repurchase of Common Stock | -- | -$2.7M | -$867K | -$1.7M | -$2.7M | |
Other Financing Activities | -$16.5M | -$693K | -$1.4M | -$11.5M | -$5.8M | |
Cash From Financing | $663.5M | $247.6M | -$2.3M | $18.2M | $196.1M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $567M | -$180M | -$126.2M | -$223.9M | -$2.5M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$96.5M | -$206.5M | -$345M | -$240.9M | -$200.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$26.1M | -$25.4M | -$25.8M | -$85.6M | $8.8M | |
Depreciation & Amoritzation | $490K | $1.1M | $2.2M | $10M | $8.5M | |
Stock-Based Compensation | $307K | $3.2M | $2.2M | $2.7M | $3.4M | |
Change in Accounts Receivable | -- | -- | -- | -- | -$1.5M | |
Change in Inventories | -- | -- | -- | -$648K | -$596K | |
Cash From Operations | -$20.6M | -$16.9M | -$14.8M | -$39.2M | -$38.9M | |
Capital Expenditures | -- | -- | -- | -- | $15M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$33.9M | -$105.1M | $52.7M | $32M | -$15M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | $16.4M | |
Long-Term Debt Repaid | -- | -- | -- | -$253.2M | -- | |
Repurchase of Common Stock | -- | -$1M | -$277K | -$598K | -$1.7M | |
Other Financing Activities | -$4.5M | -$785K | -$1.4M | -$1.7M | -$3.4M | |
Cash From Financing | $294M | $248.2M | -$1.6M | -$255.4M | $49.8M | |
Beginning Cash (CF) | $330.6M | $263.9M | $227.5M | $302.5M | $41.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $239.5M | $126.2M | $36.4M | -$262.6M | -$4M | |
Ending Cash (CF) | $570.1M | $390M | $263.9M | $39.9M | $37.5M | |
Levered Free Cash Flow | -$54.5M | -$69.1M | -$61.4M | -$53.5M | -$53.9M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.